交易中 04-01 10:44:50 美东时间
-0.150
-0.76%
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
今日重点评级关注:花旗:维持Telix Pharmaceuticals"买入"评级,目标价从22美元升至22.5美元;摩根士丹利:维持Vir Biotechnology"超配"评级,目标价从20美元升至24美元
02-25 11:03
今日重点评级关注:HC Wainwright & Co.:维持Ardelyx"买入"评级,目标价从10美元升至18美元;Truist Securities:维持Praxis Precision Medicine"买入"评级,目标价从500美元升至700美元
02-23 08:56
BUZZ-U.S. STOCKS ON THE MOVE-Comfort Systems, Funko, Paymentus Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes jumped on Friday after the Supreme Court rul
02-20 23:52
Barclays analyst Alex Scott maintains Ategrity Specialty (NYSE:ASIC) with a Overweight and raises the price target from $25 to $26.
02-20 23:07
BRIEF-Ategrity Specialty Insurance Says On Feb 12, Board Authorized $50 Mln Share Repurchase Program Feb 19 (Reuters) - Ategrity Specialty Insurance Company Holdings ASIC.N : ATEGRITY SPECIALTY INSURANCE CO HOLDINGS - ON FEB 12,BOARD AUTHORIZES $50 MILLION SHARE REPURCHASE PROGRAM - SEC FILING Sourc
02-20 05:48
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
今日重点评级关注:HC Wainwright & Co.:维持NioCorp Developments"买入"评级,目标价从9.5美元升至11.25美元;摩根士丹利:维持Chewy"超配"评级,目标价从48美元升至51美元
01-14 11:25
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22